Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Jun 01  •  04:00PM ET
0.1684
Dollar change
+0.0209
Percentage change
14.17
%
Today, 1:01 PMShareholder letter on artificial heart progress and debt cuts fuels PMI retail surge
Index
RUT
P/E
-
EPS (ttm)
-0.45
Insider Own
66.81%
Shs Outstand
75.26M
Perf Week
11.52%
Market Cap
15.55M
Forward P/E
-
EPS next Y
-0.09
Insider Trans
0.00%
Shs Float
30.65M
Perf Month
-62.99%
Enterprise Value
18.70M
PEG
-
EPS next Q
-0.03
Inst Own
0.43%
Perf Quarter
-84.41%
Income
-29.85M
P/S
2.84
EPS this Y
77.33%
Inst Trans
-0.08%
Perf Half Y
-91.94%
Sales
5.48M
P/B
-
EPS next Y
47.06%
ROA
-250.68%
Perf YTD
-90.38%
Book/sh
-0.02
P/C
129.60
EPS next 5Y
-
ROE
-
52W High
13.68 -98.77%
Perf Year
-
Cash/sh
0.00
P/FCF
-
EPS past 3/5Y
-27.88% -
ROIC
-
52W Low
0.11 53.09%
Perf 3Y
-
Dividend Est.
-
EV/EBITDA
-
Sales past 3/5Y
6.30% -
Gross Margin
7.14%
Volatility
19.74% 21.76%
Perf 5Y
-
Dividend TTM
-
EV/Sales
3.41
EPS Y/Y TTM
-19.57%
Oper. Margin
-265.15%
ATR (14)
0.05
Perf 10Y
-
Dividend Ex-Date
-
Quick Ratio
0.16
Sales Y/Y TTM
80.70%
Profit Margin
-545.06%
RSI (14)
26.58
Recom
-
Dividend Gr. 3/5Y
- -
Current Ratio
0.75
EPS Q/Q
-16.65%
SMA20
-6.76%
Beta
-
Target Price
-
Payout
-
Debt/Eq
-
Sales Q/Q
85.48%
SMA50
-72.32%
Rel Volume
2.78
Prev Close
0.15
Employees
75
LT Debt/Eq
-
SMA200
-94.38%
Avg Volume
7.89M
Price
0.17
IPO
Aug 29, 2025
Option/Short
No / Yes
Trades
Volume
21,932,392
Change
14.17%
Date Action Analyst Rating Change Price Target Change
May-18-26Initiated H.C. Wainwright Neutral
May-29-26 07:00AM
May-21-26 07:00AM
May-05-26 08:00AM
Apr-30-26 08:00AM
Apr-29-26 08:00AM
07:00AM Loading…
Apr-22-26 07:00AM
Apr-16-26 06:56PM
Apr-15-26 08:00AM
Apr-12-26 11:59PM
Apr-02-26 08:00AM
Apr-01-26 08:00AM
Mar-25-26 07:00AM
Mar-24-26 03:43PM
Mar-23-26 02:56PM
Mar-20-26 09:00AM
08:00AM Loading…
08:00AM
Mar-19-26 08:00AM
Mar-17-26 07:00AM
Mar-13-26 06:00AM
Mar-12-26 04:05PM
Mar-02-26 08:00AM
Feb-26-26 08:00AM
Feb-23-26 08:00AM
Feb-14-26 11:26AM
Feb-12-26 08:30AM
Feb-10-26 04:05PM
Feb-05-26 04:05AM
Jan-29-26 04:05PM
Jan-13-26 09:00AM
Jan-12-26 08:30AM
08:00AM Loading…
Jan-07-26 08:00AM
Jan-06-26 08:00AM
Dec-30-25 08:00AM
Dec-26-25 06:25AM
Dec-24-25 09:36AM
Dec-18-25 08:55AM
08:30AM
Dec-09-25 04:05PM
Dec-03-25 04:05PM
Nov-26-25 07:00AM
Nov-19-25 04:05PM
Nov-14-25 07:00AM
Nov-12-25 08:00AM
Nov-03-25 08:00AM
Oct-24-25 03:07PM
Oct-08-25 10:51AM
Sep-22-25 08:00AM
Sep-15-25 08:00AM
Sep-10-25 08:00AM
Sep-09-25 04:05PM
Sep-08-25 07:00AM
Sep-02-25 04:05PM
Picard Medical, Inc. is a medical technology company, which manufactures and sells the only U.S. FDA, and Health Canada approved implantable SynCardia TAH. It develops the first fully implantable SynCardia TAH as an alternative to heart transplantation for patients with biventricular heart failure in the U.S. and around the world. The company is headquartered in Tucson, AZ.
CEO & DirectorMr. Patrick N. J. Schnegelsberg
Chief Financial OfficerMr. Bernard Skaggs
Chief Operating OfficerMr. Matthew Schuster
Chief Technology Officer of SynCardia SystemsDr. Frank Tinker Ph.D.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sindex SSI Lending, LLC10% OwnerJun 01 '26Proposed Sale0.183,971,793695,064Jun 01 05:36 PM